Celgene, Astellas Hit Fresenius With Lymphoma Drug IP Suit
Celgene Corp. and Astellas Pharma Inc. sued generic-drug maker Fresenius Kabi USA LLC in Delaware federal court Wednesday, alleging the manufacturer violated patents for the cancer drug Istodax....To view the full article, register now.
Already a subscriber? Click here to view full article